UK to save on generic medicines bill

	Tweet

The British government expects to save about 300 million pounds ($545 million) a year on the cost of generic medicines to the state sector, under a five-year agreement signed with industry, officials said on Wednesday.

The new deal allows for reductions in the price paid by the National Health Service for generic, or unpatented, medicines if the market rate offered by manufacturers to wholesalers falls.

The previous scheme worked by setting a maximum price for generics.

Jane Kennedy, the junior health minister, said the new arrangements would promote a more transparent and competitive market for generic drugs.

Britain already has one of the highest rates of generic drug use in Europe, with unbranded prescription medicines accounting for more than half of the overall market by volume but less than 20 percent in terms of value. 

RELATED STORIES:
New vaccine may help fight leukaemia: study   FDA Approves New Insomnia Drug   Half of Internet “Viagra” could be fake: study   Cheap new combination pill to help fight malaria   Two Abbott HIV drug ads misleading, FDA says   UK scientists develop new vaccine technology   Glaxo Seeks Entry Into U.S. Flu Vaccine Mkt   Asia nations agree to stockpile anti-bird flu drugs   Pfizer stops all Torcetrapib trials   Experts say new drugs needed to fight flu pandemic   State negotiating purchase of flu vaccine in Europe   Health advisers revive Merck’s Vioxx

Comments

[ + Post Your Own ]

Now you're in the public comment zone. What follows is not Armenian Medical Network's stuff; it comes from other people and we don't vouch for it. A reminder: By using this Web site you agree to accept our Terms of Service. Click here to read the Rules of Engagement.

There are no comments for this entry yet. [ + Comment here + ]